Evidence map›Paper›PMID 26456482›Full record

ArticlePharmacoepidemiology and drug safety2015

The adherence-outcome relationship is not altered by diary-driven adjustments of microelectronic monitor data.

Jessica Eby, Jennifer Chapman, Tafireyi Marukutira, Gabriel Anabwani, Ontibile Tshume, Omphile Lepodisi, Tebo Dipotso, Keboletse Mokete, Robert Gross, Elizabeth Lowenthal

Registry-linked trialAbstract read
In one paragraph

Article in Pharmacoepidemiology and drug safety, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03302299 (URBAN ARCH), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03302299 phase4completednot on this mapstarted 2017, after this paper: background citation

URBAN ARCH (3/5) Uganda Cohort TB Preventive Therapy for HIV-infected Alcohol Users in Uganda: an Evaluation of Safety Tolerability and Adherence

TypeinterventionalSponsorUniversity of California, San FranciscoRan2017 to 2021Enrolled302ConditionsTuberculosis, HIV/AIDS, Alcohol AbuseArmsIsoniazid 300 Mg ORAL TABLET, Pyridoxine 25 Mg Oral Tablet
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Trends in HIV Treatment Adherence Before and After HIV Status Disclosure to Adolescents in Botswana.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2020
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jessica EbyChildren's Hospital of Philadelphia, Philadelphia, PA, USA.
Jennifer ChapmanChildren's Hospital of Philadelphia, Philadelphia, PA, USA.
Tafireyi MarukutiraBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.
Gabriel AnabwaniBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.
Ontibile TshumeBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.
Omphile LepodisiBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.
Tebo DipotsoBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.
Keboletse MoketeBotswana-Baylor Children's Clinical Centre of Excellence, Gaborone, Botswana.
Robert GrossPerelman School of Medicine, Departments of Medicine and Epidemiology, University of Pennsylvania, Philadelphia, PA, USA.
Elizabeth LowenthalChildren's Hospital of Philadelphia, Philadelphia, PA, USA.

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI VINCENT LO RE · 1999 to 2026
$78.6M
Targeted Monitoring and Determinants of Adherence in Adolescents with HIVK23MH095669 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI LOWENTHAL, ELIZABETH DAWN · 2012 to 2016
$874k
NIAID NIH HHS P30 AI 045008NIAID NIH HHS P30 AI045008NIMH NIH HHS K23 MH095669
6 · The paper itself

Abstract

purposeThe purpose of this study was to determine whether diary-driven adjustment of Medication Event Monitoring System (MEMS) data based on Supporting Information strengthens the relationship between measured antiretroviral medication adherence and plasma HIV viral load (VL).

methodsHIV+ adolescents on antiretroviral treatment were monitored with MEMS for 30 days preceding a VL measurement. The primary outcome was VL ≥ 400 copies/mL. Handwritten diaries were used to comprehensively record deviations from recommended use (bottle opened but dose not taken or bottle not opened and dose taken). Data were adjusted ("cleaned") based on diary events. Data were "capped" at the prescribed number of doses/day. Receiver operator characteristic analysis compared the relationships between (i) raw MEMS data, (ii) diary-cleaned, (iii) capped, or (iv) cleaned and capped MEMS data and VL.

resultsOver 30 days preceding VL measurements, 273 adolescents had 465 diary events. Capping resulted in fewer patients classified as 95% adherent (65.2%) compared with raw data (71.4%), p < 0.001. Adherence was highly associated with VL (OR 1.05, p < 0.001). The area under the receiver operating characteristic curve for continuous adherence compared with VL was 0.89 (95%CI: 0.82-0.95). Neither diary-cleaning, capping, nor cleaning and capping MEMS data significantly altered the association between adherence and VL (p = 0.14, 0.40, and 0.19, respectively).

conclusionMedication Event Monitoring System data-cleaning based on diary entries did not affect the adherence-VL relationship.

Indexed as

Drug MonitoringPatient ComplianceAdolescentAdolescent Health ServicesAnti-HIV AgentsBotswanaChildDrug Administration ScheduleFemaleHIV InfectionsHumansMaleMedical RecordsYoung AdultAnti-HIV Agentsadherenceelectronic monitoringHIVMEMS, self-reportpharmacoepidemiology

Identifiers

PMID26456482
PMCPMC4715738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.